***Official*** 2010 Stock Market Thread

Page 46 - Seeking answers? Join the AnandTech community: where nearly half-a-million members share solutions and discuss the latest tech.

Regs

Lifer
Aug 9, 2002
16,666
21
81
1.06 and climbing pre-market...

might be some life in it yet.

Edit: I'm listening to the conference now and it seems like GNVC is going end up being a long term hold. I feel sorry for people who held this stock for this long and still not get anywhere with it.

They have a few full funded projects like vaccines and the hearing loss program with novartis. Problem is, most of these products are no where near marketability or commercialization yet. Pre-clinical products can take a decade to reach the market if at all. Bascially, this stock is better to be forgotten for a very long time.

This stock may very well go down to .30 once everybody gets wind of the news. They will have troubles again with delisting notices from the NASDAQ in the next 30 days.
 
Last edited:

Jassi

Diamond Member
Sep 8, 2004
3,296
0
0
Holy shit that news hurt. I don't know what I'm going to do...... Good thing I didn't cost average up.
 

Riverhound777

Diamond Member
Aug 13, 2003
3,360
61
91
Wow that sucks... I thought i'd dabble a bit just in case something huge happened. Picked up 150 shares a few days ago for the heck of it. Oh well, at least it wasn't a huge investment. Lesson learned.
 

richardycc

Diamond Member
Apr 29, 2001
5,719
1
81
bought some gnvc at .7522...Cmon, dead cat bounce! this is a purely trading play now, unless you want to hold it long term.
 

Dubb

Platinum Member
Mar 25, 2003
2,495
0
0
well, I'm out @ $0.81 or so. around a 33% loss.

Might have been better to hang on to it, but there's less uncertainty this way.

Lessons - new territory is uncertain. As good as the research history on TNF-alpha was, it doesn't mean much if they can't effectively get it where it matters.

and, let's not forget - while we're all licking our wounds, this also means that people with pancreatic cancer now have a little less hope in the world. While it sounds cornball, money really doesn't matter much in the face of that.

now, what to do with the money I'm left with? will probably sit on it for a while, though BDX is still kind of tempting.
 

destrekor

Lifer
Nov 18, 2005
28,799
359
126
you didn't see the rumor that Pfe is interested in the company?

is there any particular weight to this rumor?

So far I'm intrigued at the price's ability to stick to 2.30+ so far. Making me less worried about trying to beat a severe drop today. Now tomorrow morning on the other hand. :)
 

richardycc

Diamond Member
Apr 29, 2001
5,719
1
81
wow 200000shares bid at 0.7999 for gnvc...and now 177300 at 0.80, something is up or just swing traders coming in now?
 

richardycc

Diamond Member
Apr 29, 2001
5,719
1
81

Regs

Lifer
Aug 9, 2002
16,666
21
81
Well there is some light at the end of the tunnel:
http://www.forbes.com/2010/03/30/genvec-trial-novartis-markets-equities-cancer.html?partner=yahootix


"15% chance of clinical success, the opportunity in the $4.5 billion hearing loss market -- where industry standard is hearing aids and not pharmaceuticals -- GenVec shares could get a major boost if the treatment can show encouraging results in early-stage trials."

Again , that is years away and after how well this trial went, the confidence in Genvec will be fully diminished. It seems like GNVC has a history of "what-ifs" and "could-ofs.
 
Last edited:

richardycc

Diamond Member
Apr 29, 2001
5,719
1
81
bought more GNVC at .7897 in my 'bought and forget' account. Will hold it for a few yrs. It should gap up tomorrow.
 

richardycc

Diamond Member
Apr 29, 2001
5,719
1
81
After seeing millions of shares sold at .79 cents, I doubt it.

I don't get your logic, for millions of shares sold, those shares were bought by someone. With a big drop like today, more often than not it will usually gap up the next day. It's already 82cents AH, but who knows.
 

HopJokey

Platinum Member
May 6, 2005
2,110
0
0
Alright.... thoughts on TNDM?

TNDM is a recommendation of a stock service I subscribe to (Motley Fool Hidden Gems). Other than that I really haven't looked too closely to them. All I know is that their bread and butter is based on royalties collected from plain old telephone services and that they are trying to translate that model somehow to "new school" aka VOIP and Internet stuff.

They are too speculative for me as I only have room for one of those in my portfolio (GNVC, which I recently got rid of). The rest are value/longer term plays.

I'll dig deeper into what the Hidden Gems members have to say about Neutral Tandem if you want.
 
Last edited:

HopJokey

Platinum Member
May 6, 2005
2,110
0
0
dude, I lost a Nissan's new electric car on paper today.

Ouch.

Was there any big red flags? The dilluation? Anything else? It looked like at worse the HR was going to be .80 NOT .92 and shut down. I thought if they were going to shut down the trial it would have to be because of some adverse event not simply "TNFerade sucks on PC".
 

Regs

Lifer
Aug 9, 2002
16,666
21
81
I don't get your logic, for millions of shares sold, those shares were bought by someone. With a big drop like today, more often than not it will usually gap up the next day. It's already 82cents AH, but who knows.

124.87M shares oustanding, and today alone traded over 85 million shares. If there were any gap, it was between .40 after premarket to the new high of .80.
 

Regs

Lifer
Aug 9, 2002
16,666
21
81
Ouch.

Was there any big red flags? The dilluation? Anything else? It looked like at worse the HR was going to be .80 NOT .92 and shut down. I thought if they were going to shut down the trial it would have to be because of some adverse event not simply "TNFerade sucks on PC".

This article was pretty accurate:

http://www.thestreet.com/story/10448931/1/genvec-stock-hit-by-pancreas-studys-details.html

Though I would of played the stock exactly as I would have in hindsight. It was a high risk, high reward stock. I lost 2 grand, but it's a lot better than missing out the chance of making 15k+. The chance of a drug lower risk of death of 20-25% in a market where no other drug really comes close would of been big.

The dilution well calculated financing at the most opportune time. If the trial succeeded, they would of had enough cash to see the project through. If they failed, they would have enough to concentrate on their vaccine platform and their hearing loss program. At least now they don't have to worry about the cash burn of a phase 3 drug candidate.
 
Last edited: